The SNPs in the processes of apoptosis and inflammation (CDKN2BAS rs10757278 +501A>G and IL6R rs2228145 +501A>C) and cholesterol metabolism (LPA rs3798220 +501T>C and SORT1 rs599839 +813A>G) represent risk factors for the development of AAA, while the SNP DAB2IP rs7025486 +501G>A has a protective effect. The gene discussed is DAB2IP; the disease is triple-A syndrome.